Methamphetamine exposure and chronic illness in police officers: Significant improvement with sauna-based detoxification therapy

Toxicology and Industrial Health

Volumn 28, Issue 8, 2012, Pages 758-768

  Ross, Gerald H ^a   Sternquist, Marie C ^b  

^a C/o American Detoxification Foundation ^*  (United States)

^b Foundation for Advancements in Science and Education   (United States)

Author keywords

chemical exposure; contamination; detoxification; Methamphetamine; police; sauna

Indexed keywords

METHAMPHETAMINE; NICOTINIC ACID;

ADULT; AEROBIC EXERCISE; CHRONIC DISEASE; DETOXIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROTOXICITY; NUTRITIONAL SUPPORT; OCCUPATIONAL EXPOSURE; POLICE; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SAUNA; SHORT FORM 36;

ADULT; BEHAVIORAL SYMPTOMS; CHRONIC DISEASE; EXERCISE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENTAL HEALTH; METHAMPHETAMINE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; POLICE; RETROSPECTIVE STUDIES; STEAM BATH; TREATMENT OUTCOME;

EID: 84864842459     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233711425070     Document Type: Review

References (42)

1. Alexson O, Hogstedt C Occupational Medicine. Zenz C Dickerson OB Horvath EP, ed. St. Louis: Mosby Press ; 1994: 764-768.
2. Betsinger G. Coping with meth lab hazards. Occupational Health and Safety. 2006 ; 75 (11). 50 52 54-58
3. Burgess JL. Phosphine exposure from a methamphetamine laboratory investigation. Journal of Toxicology. Clinical Toxicology. 2001 ; 39 (2). 165-168
4. Burgess JL, Barnhart S, Checkoway H. Investigating clandestine drug laboratories: adverse medical effects in law enforcement personnel. American Journal of Industrial Medicine. 1996 ; 30 (4). 488-494
5. Burgess JL, Kovalchick DF, Siegel EM, Hysong TA, McCurdy SA. Medical surveillance of clandestine drug laboratory investigators. Journal of Occupational and Environmental Medicine. 2002 ; 44 (2). 184-189
6. Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environmental Health Perspective. 2002 ; 110 (suppl 1). 25-42
7. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories-selected states, 1996-1999. MMWR Morbidity and Mortality Weekly Report. 2000 ; 49 (45). 1021-1024
8. Recognition of illness associated with exposure to chemical agents-United States, 2003. MMWR Morbidity and Mortality Weekly Report. 2003 ; 52 (39). 938-940
9. Acute public health consequences of methamphetamine laboratories-16 states, January 2000-June 2004. MMWR Morbidity and Mortality Weekly Report. 2005 ; 54 (14). 356-359
10. Cecchini M, LoPresti V. Drug residues store in the body following cessation of use: impacts on neuroendocrine balance and behavior-use of the Hubbard sauna regimen to remove toxins and restore health. Medical Hypotheses. 2007 ; 68 (4). 868-879
11. Cecchini MA, Root DE, Rachunow JR, Gelb PM. Chemical exposures at the World Trade Center: use of the Hubbard sauna detoxification regimen to remove toxins and restore health. Townsend Letter. 2006 ; 273: 58-65
12. Crinnion W. Components of practical clinical detox programs-sauna as a therapeutic tool. Alternative Therapies in Health and Medicine. 2007 ; 13 (2). S154 - S156
13. Dahlgren J, Cecchini M, Takhar H, Paepke O. Persistent organic pollutants in 9/11 world trade center rescue workers: reduction following detoxification. Chemosphere. 2007 ; 69 (8). 1320-1325
14. The threat of meth. Environmental Health Perspectives. 1998 ; 106: A172 - A173
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975 ; 12 (3). 189-198
16. Garwood ER, Bekele W, McCulloch CE, Christine CW. Amphetamine exposure is elevated in Parkinson's disease. Neurotoxicology. 2006 ; 27 (6). 1003-1006
17. Hall HV, McPherson SB, Twemlow SW, Yudko E Methamphetamine Use: Clinical and Forensic Aspects. Yudko E Hall HV McPherson SB, ed. Boca Raton: CRC Press ; 2003): 13-15.
18. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Economics. 1993 ; 2 (3). 217-227
19. Herpin G, Gargouri I, Gauchard GC, Nisse C, Khadhraoui M. Effect of chronic and subchronic organic solvents exposure on balance control of workers in plant manufacturing adhesive materials. Neurotoxicity Research. 2009 ; 15 (2). 179-186
20. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology and Metabolism. 2002 ; 87 (2). 489-499
21. Hubbard LR Clear Body Clear Mind. 1990 ) Clear Body Clear Mind. 2002 ed. Los Angeles: Bridge Publications. Los Angeles: Bridge Publications ; 1990 :
22. Kilburn KH, Warsaw RH, Shields MG. Neurobehavioral dysfunction in firemen exposed to polycholorinated biphenyls (PCBs): possible improvement after detoxification. Archives of Environmental Health. 1989 ; 44 (6). 345-350
23. Leonard KL. Is patient satisfaction sensitive to changes in the quality of care? An exploitation of the Hawthorne effect. Journal of Health Economics. 2008 ; 27 (2). 444-59
24. Levisky JA, Bowerman DL, Jenkins WW, Johnson DG, Karch SB. Drugs in postmortem adipose tissues: evidence of antemortem deposition. Forensic Science International. 2001 ; 121 (3). 157-160
25. MarshallDR (2000) Report before the 106th congress: emerging drug threats and perils facing Utah's youth. Salt Lake City, UT: Committee on the Judiciary, United States Senate. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi? dbname=106-senate-hearings&docid=f:73821.pdf(accessed 17 April 2011)
26. MartynyJWArbuckleSLMcCammonCSEssweinEJErbN (2004) Chemical exposures associated with clandestine methamphetamine laboratories. Denver, CO: National Jewish Medical and Research Centerwww.nationaljewish.org/pdf/chemical-exposures. pdf. (accessed 17 April 2011).
27. MartynyJWVan DykeMVMcCammonCSErbNArbuckleSL (2005a) Chemical exposures associated with clandestine methamphetamine laboratories using the anhydrous ammonia method of production. Denver, CO: National Jewish Medical and Research Center. http://www.njc.org/pdf/Ammonia%20Meth.pdf. (accessed 17 April 2011).
28. MartynyJWVan DykeMMcCammonCSErbNArbuckleSL. (2005b). Chemical exposures associated with clandestine methamphetamine laboratories using the hypophosphorous and phosphorous flake method of production. National Jewish Medical Research Centerhttp://www.njc.org/pdf/meth-hypo-cook.pdf(Accessed 9 Feb 2011).
29. Miller MD, Crofton KM, Rice DC, Zoeller RT. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environmental Health Perspectives. 2009 ; 117 (7). 1033-1041
30. Rea WJ, Pan Y, Johnson AR, Ross GH, Suyama H, Fenyves EJ. Reduction of chemical sensitivity by means of heat depuration, physical therapy and nutritional supplementation. Journal of Nutritional and Environmental Medicine. 1996 ; 6: 141-148
31. Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clinical Toxicology (Philadelphia). 2010 ; 48 (7). 675-694
32. Schnare DW, Ben M, Shields MG. Body burden reduction of PCBs, PBBs and chlorinated pesticides in human subjects. Ambio. 1984 ; 13: 378-380
33. Schnare DW, Denk G, Shields M, Brunton S. Evaluation of a detoxification regimen for fat stored xenobiotics. Medical Hypotheses. 1982 ; 9 (3). 265-282
34. Sharpe RM. The 'oestrogen hypothesis'- where do we stand now?. International Journal of Andrology. 2003 ; 26 (1). 2-15
35. Singer R Neurotoxicity Guidebook. San Diego, CA: Aventine Press ; 2006 :
36. Thrasher DL, Von Derau K, Burgess J. Health effects from reported exposure to methamphetamine labs: a poison center-based study. Journal of Medical Toxicology. 2009 ; 5 (4). 200-204
37. Tretjak Z, Beckmann S, Tretjak A, Gunnerson C Post-Audits of Environmental Programs and Projects; Proceedings, Environmental Impact Analysis Research Council / ASCE. LA: New Orleans ; 1989: 57-72.
38. Tretjak Z, Shields M, Beckmann SL. PCB reduction and clinical improvement by detoxification: an unexploited approach?. Human and Experimental Toxicology. 1990 ; 9 (4). 235-244
39. Tsyb AF, Parshkov EM, Barnes J, Yarzutkin VV, Vorontsov NV, Dedov VI. Proceedings of the 1998 International Radiological Postemergency Response Issues Conference. 1998 ;: 162 178-166 182
40. Witter RZ, Martyny JW, Mueller K, Gottschall B, Newman LS. Symptoms experienced by law enforcement personnel during methamphetamine lab investigations. Journal of Occupational and Environmental Hygiene. 2007 ; 4 (12). 895-902
41. Woodruff TJ. Bridging epidemiology and model organisms to increase understanding of endocrine disrupting chemicals and human health effects. The Journal of Steroid Biochemistry and Molecular Biology. 2011 ; 127 (1 2). 108-117
42. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. The New England Journal of Medicine. 2010 ; 363 (2). 123-135